Two FDA scientists have received the US Patent and Trademark Office’s Patents for Humanity Award for their work in developing a meningitis vaccine used in sub-Saharan Africa.
The award recognized Che-Hung Robert Lee, PhD, and Carl Frasch, PhD, who worked in the FDA’s Office of Vaccine Research and Review in 2003 when they collaborated on the vaccine, now called MenAfriVac. Their research culminated in the development of an alternative conjugation technology that stimulated the immune system more efficiently and was less costly than the existing method.
Voelker R. Scientists Receive Award for Meningitis Vaccine Research. JAMA. 2017;317(7):688. doi:10.1001/jama.2017.0839